Cargando…
Selective activator protein‐1 inhibitor T‐5224 prevents lymph node metastasis in an oral cancer model
Activator protein‐1 (AP‐1) is a transcriptional factor that regulates the expression of various genes associated with tumor invasion and migration. The purpose of our study was to assess the therapeutic effects of a novel selective AP‐1 inhibitor, T‐5224, in preventing lymph node metastasis in head...
Autores principales: | Kamide, Daisuke, Yamashita, Taku, Araki, Koji, Tomifuji, Masayuki, Tanaka, Yuya, Tanaka, Shingo, Shiozawa, Shunichi, Shiotani, Akihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970834/ https://www.ncbi.nlm.nih.gov/pubmed/26918517 http://dx.doi.org/10.1111/cas.12914 |
Ejemplares similares
-
Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma
por: Yamashita, Taku, et al.
Publicado: (2016) -
Value of transoral surgery for human papillomavirus-mediated oropharyngeal cancer: validation of a new staging system in Japanese patients
por: Kimura, Eiko, et al.
Publicado: (2019) -
TrkA inhibitor promotes motor functional regeneration of recurrent laryngeal nerve by suppression of sensory nerve regeneration
por: Suzuki, Hiroshi, et al.
Publicado: (2020) -
Gene Therapy of c-myc Suppressor FUSE-Binding Protein-Interacting Repressor by Sendai Virus Delivery Prevents Tracheal Stenosis
por: Mizokami, Daisuke, et al.
Publicado: (2015) -
Gene Therapy for Recurrent Laryngeal Nerve Injury
por: Araki, Koji, et al.
Publicado: (2018)